Amjad Husain

905 total citations
20 papers, 639 citations indexed

About

Amjad Husain is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Amjad Husain has authored 20 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Cancer Research and 4 papers in Biomedical Engineering. Recurrent topics in Amjad Husain's work include Protein Degradation and Inhibitors (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Acute Myeloid Leukemia Research (2 papers). Amjad Husain is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Acute Myeloid Leukemia Research (2 papers). Amjad Husain collaborates with scholars based in United States, India and Saudi Arabia. Amjad Husain's co-authors include Siddappa N. Byrareddy, Ramaswamy Krishnan, Sari Tojkander, Gergana Gateva, Pekka Lappalainen, Carmelo Nucera, Peter M. Sadow, Mohd Rehan, Mohd Suhail and Seema Sehrawat and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Blood.

In The Last Decade

Amjad Husain

20 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amjad Husain United States 13 285 152 113 72 70 20 639
Xiulei Mo United States 14 357 1.3× 57 0.4× 104 0.9× 25 0.3× 69 1.0× 24 556
István Kurucz Hungary 17 561 2.0× 151 1.0× 76 0.7× 29 0.4× 50 0.7× 42 960
Björn Koos Germany 15 478 1.7× 59 0.4× 67 0.6× 24 0.3× 105 1.5× 41 719
Ludovic D’Auria Belgium 17 525 1.8× 181 1.2× 53 0.5× 31 0.4× 42 0.6× 23 805
James W.A. Ritchie United Kingdom 10 848 3.0× 38 0.3× 317 2.8× 75 1.0× 49 0.7× 11 1.2k
Ya‐Ju Hsieh Taiwan 14 509 1.8× 103 0.7× 104 0.9× 17 0.2× 167 2.4× 29 876
Sarah A. Head United States 14 465 1.6× 45 0.3× 133 1.2× 121 1.7× 16 0.2× 32 854
Daniel Floryk United States 13 406 1.4× 46 0.3× 63 0.6× 52 0.7× 16 0.2× 17 568
Jennifer C. Byrne Ireland 17 464 1.6× 52 0.3× 111 1.0× 52 0.7× 29 0.4× 26 927
Christine Orr Canada 10 569 2.0× 61 0.4× 171 1.5× 47 0.7× 12 0.2× 15 836

Countries citing papers authored by Amjad Husain

Since Specialization
Citations

This map shows the geographic impact of Amjad Husain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amjad Husain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amjad Husain more than expected).

Fields of papers citing papers by Amjad Husain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amjad Husain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amjad Husain. The network helps show where Amjad Husain may publish in the future.

Co-authorship network of co-authors of Amjad Husain

This figure shows the co-authorship network connecting the top 25 collaborators of Amjad Husain. A scholar is included among the top collaborators of Amjad Husain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amjad Husain. Amjad Husain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suhail, Mohd, Mohd Rehan, Mohammad Tarique, et al.. (2023). Targeting a transcription factor NF-κB by green tea catechins using in silico and in vitro studies in pancreatic cancer. Frontiers in Nutrition. 9. 1078642–1078642. 33 indexed citations
2.
Bhat, Anjali, Deepak Kumar, Pravindra Kumar, et al.. (2022). RNA splicing: a dual-edged sword for hepatocellular carcinoma. Medical Oncology. 39(11). 173–173. 10 indexed citations
3.
Husain, Amjad, et al.. (2021). Substrate stiffening promotes VEGF-A functions via the PI3K/Akt/mTOR pathway. Biochemical and Biophysical Research Communications. 586. 27–33. 23 indexed citations
4.
Ashraf, Ghulam Md, Mahmoud Ahmed Ebada, Mohd Suhail, et al.. (2021). Dissecting Sex‐Related Cognition between Alzheimer’s Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies. Oxidative Medicine and Cellular Longevity. 2021(1). 4572471–4572471. 9 indexed citations
5.
6.
Kashyap, Manoj Kumar, et al.. (2021). Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment. Molecular and Cellular Biochemistry. 476(11). 3911–3922. 8 indexed citations
7.
Aggarwal, Nikita, Yeshvandra Verma, Hatem Zayed, et al.. (2021). Tumor reversion: a dream or a reality. Biomarker Research. 9(1). 31–31. 13 indexed citations
8.
Husain, Amjad & Siddappa N. Byrareddy. (2020). Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19. Chemico-Biological Interactions. 331. 109282–109282. 60 indexed citations
9.
Kumar, Pravindra, et al.. (2020). Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19. Molecular and Cellular Biochemistry. 476(2). 553–574. 28 indexed citations
10.
Suhail, Mohd, et al.. (2019). Exploring Inhibitory Mechanisms of Green Tea Catechins as Inhibitors of a Cancer Therapeutic Target, Nuclear Factor-κB (NF-κB). Biosciences Biotechnology Research Asia. 16(4). 715–723. 13 indexed citations
11.
Rajendran, K., Quynh Dang, Amjad Husain, et al.. (2018). Traction Force Screening Enabled by Compliant PDMS Elastomers. Biophysical Journal. 114(9). 2194–2199. 44 indexed citations
12.
Kumar, Naveen, et al.. (2018). Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment. Molecular and Cellular Biochemistry. 447(1-2). 77–92. 30 indexed citations
13.
Drusbosky, Leylah, Kimberly E. Hawkins, Shireen Vali, et al.. (2017). Abstract CT085: iCare 1: A prospective clinical trial to predict treatment response based on mutanome-informed computational biology in patients with AML and MDS. Cancer Research. 77(13_Supplement). CT085–CT085. 2 indexed citations
14.
Drusbosky, Leylah, Elizabeth Wise, Shireen Vali, et al.. (2016). Icare 1: A Prospective Clinical Trial to Predict Treatment Response Based on Mutanome-Informed Computational Biology in Patients with AML and MDS. Blood. 128(22). 594–594. 1 indexed citations
15.
Husain, Amjad, et al.. (2015). Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF. Cancer Letters. 380(2). 577–585. 12 indexed citations
16.
Tojkander, Sari, Gergana Gateva, Amjad Husain, Ramaswamy Krishnan, & Pekka Lappalainen. (2015). Generation of contractile actomyosin bundles depends on mechanosensitive actin filament assembly and disassembly. eLife. 4. e06126–e06126. 107 indexed citations
17.
Connor, Yamicia, Amjad Husain, Venkata Sabbisetti, et al.. (2015). Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype. Nature Communications. 6(1). 8671–8671. 66 indexed citations
18.
Rashid, Mohd, Asif Husain, Ravinesh Mishra, et al.. (2015). Design and synthesis of benzimidazoles containing substituted oxadiazole, thiadiazole and triazolo-thiadiazines as a source of new anticancer agents. Arabian Journal of Chemistry. 12(8). 3202–3224. 65 indexed citations
19.
Duquette, Mark, Peter M. Sadow, Amjad Husain, et al.. (2015). Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model. Oncotarget. 6(40). 42445–42467. 36 indexed citations
20.
Shaik, Shavali, Carmelo Nucera, Hiroyuki Inuzuka, et al.. (2012). SCFβ-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2. The Journal of Experimental Medicine. 209(7). 1289–1307. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiulei Mo Breakdown of academic impact, for papers by István Kurucz Breakdown of academic impact, for papers by Björn Koos Breakdown of academic impact, for papers by Ludovic D’Auria Breakdown of academic impact, for papers by James W.A. Ritchie Breakdown of academic impact, for papers by Ya‐Ju Hsieh Breakdown of academic impact, for papers by Sarah A. Head Breakdown of academic impact, for papers by Daniel Floryk Breakdown of academic impact, for papers by Jennifer C. Byrne Breakdown of academic impact, for papers by Christine Orr
Rankless by CCL
2026